Skip to main content
. 2017 Sep 13;20(1):21930. doi: 10.7448/IAS.20.1.21930

Figure 1.

Figure 1.

Flow chart of study and participant selection.

NNRTI: non-nucleoside reverse-transcriptase inhibitor; LPV/r: ritonavir-boosted lopinavir; VL: viral load.